Slingshot members are tracking this event:
ZIOPHARM (ZIOP) to launch Phase 1 clinical trial of off-the-shelf primary NK cells for investigational therapy of acute myeloid leukemia in 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Nov 06, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Nk Therapy, Nk Cells, Acute Myeloid Leukemia, Phase 1